Viral infections trigger a wide range of immune responses thought to drive tumorigenesis
and malignant progression. Dissecting virus‐induced changes in the tumor immune …

Large-scale assays, such as microarrays, next-generation sequencing and various “omics”
technologies, have explored multiple aspects of the immune response following virus …

Background Viral infections are prevalent in human cancers and they have great diagnostic
and theranostic values in clinical practice. Recently, their potential of shaping the tumor …

An important mechanism of oncolytic virotherapy in ameliorating cancer immunotherapy is
by inducing significant changes in the immune landscape in the tumor microenvironment …

High-throughput screens can rapidly scan and capture large amounts of information across
multiple biological parameters. Although many screens have been designed to uncover …

Understanding tumor immune microenvironments is critical for identifying immune modifiers
of cancer progression and developing cancer immunotherapies. Recent applications of …

Background Tumor Immuno-MicroEnvironment (TIME) is characterized by a heterogeneous
interplay of cellular and molecular components. For the TIME of cancers caused by virus …

Oncolytic virus (OV) therapy is a promising cancer treatment strategy, which selectively
replicates in and destroys tumor cells rather than normal cells, thereby effectively releasing …

The relationship between the immune cell and tumor occurrence and progression remains
unclear. Profiling alterations in the tumor immune microenvironment (TIME) at high …

Immunotherapies such as immune checkpoint blockade and adoptive cell transfer have
revolutionized cancer treatment, but further progress is hindered by our limited …